Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible <i>Escherichia coli</i>: A Missed Opportunity for De-Escalation of Therapy

An increasing number of reports describing <i>Escherichia coli</i> isolates with piperacillin/tazobactam resistance, despite retained cephalosporin susceptibility, suggest further emergence of this phenotypic resistance pattern. In this report, a patient with metastatic breast cancer pre...

Full description

Bibliographic Details
Main Authors: Leah Carlisle, Julie Ann Justo, Majdi N. Al-Hasan
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/7/4/104